Protocol Page


	Study ID (Protocol Number)
	CA209-040


	STUDY LOCATIONS*
	Providence Portland Medical Center Portland, OR 97213 Recruiting	Usc Norris Comprehensive Cancer Center Los Angeles, CA 90033 Recruiting
	University Of Michigan Ann Arbor, MI 48109-5331 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Multiple Ascending Dose
	STUDY OVERVIEW
	The purpose of this study is to evaluate the safety, pharmacokinetics, immunoregulatory activity, pharmacodynamics and preliminary anti-tumor activity of BMS-936558 in subjects with advanced hepatocellular carcinoma (HCC)

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.